We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+8.82%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$5.94B
AUM Growth
+$2.67B
Cap. Flow
+$2.4B
Cap. Flow %
40.37%
Top 10 Hldgs %
19.09%
Holding
6,103
New
843
Increased
2,477
Reduced
2,101
Closed
546

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$206M
2
MSFT icon
Microsoft
MSFT
+$179M
3
AMZN icon
Amazon
AMZN
+$114M
4
TSLA icon
Tesla
TSLA
+$84M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$59.8M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$685M
2
DIA icon
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
+$54.5M
3
QQQ icon
Invesco QQQ Trust
QQQ
+$42.1M
4
VOO icon
Vanguard S&P 500 ETF
VOO
+$27.7M
5
IWB icon
iShares Russell 1000 ETF
IWB
+$22.2M

Sector Composition

Rank Sector Weight
1 Technology 20.76%
2 Financials 11.47%
3 Healthcare 11.18%
4 Consumer Discretionary 10.98%
5 Communication Services 8.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TAOP icon
5051
Taoping
TAOP
$8.68M
$2K ﹤0.01%
+1
New +$2.03K
TFII icon
5052
TFI International
TFII
$11.5B
$2K ﹤0.01%
23
-3,244
-99% -$220K
UG icon
5053
United-Guardian
UG
$32.7M
$2K ﹤0.01%
154
-562
-78% -$8.07K
VRDN icon
5054
Viridian Therapeutics
VRDN
$2.66B
$2K ﹤0.01%
118
-1,274
-92% -$23.9K
VVOS icon
5055
Vivos Therapeutics
VVOS
$4.24M
$2K ﹤0.01%
+15
New +$2.68K
WGS icon
5056
GeneDx Holdings
WGS
$2.39B
$2K ﹤0.01%
4
-11
-73% -$5.72K
XPEV icon
5057
XPeng
XPEV
$11.3B
$2K ﹤0.01%
55
-126,757
-100% -$5.27M
XXII
5058
22nd Century Group
XXII
$1.5M
– –
0
– –
XWEL icon
5059
XWELL
XWEL
$8.02M
$2K ﹤0.01%
67
-904
-93% -$34.6K
YYY icon
5060
Amplify CEF High Income ETF
YYY
$742M
$2K ﹤0.01%
100
– –
ZIM icon
5061
ZIM Integrated Shipping Services
ZIM
$2.99B
$2K ﹤0.01%
+99
New +$2.04K
XTIA icon
5062
XTI Aerospace
XTIA
$60.8M
– –
0
– –
SER icon
5063
Serina Therapeutics
SER
$40.9M
$2K ﹤0.01%
43
-479
-92% -$33.5K
CYTH
5064
DELISTED
Cyclo Therapeutics, Inc. Common Stock
CYTH
$2K ﹤0.01%
+194
New +$1.62K
BMTX
5065
DELISTED
BM Technologies, Inc.
BMTX
$2K ﹤0.01%
+179
New +$2.43K
USAP
5066
DELISTED
Universal Stainless & Alloy
USAP
$2K ﹤0.01%
149
-954
-86% -$8.73K
BSMO
5067
DELISTED
Invesco BulletShares 2024 Municipal Bond ETF
BSMO
$2K ﹤0.01%
+90
New +$2.32K
VTNR
5068
DELISTED
Vertex Energy, Inc
VTNR
$2K ﹤0.01%
1,100
-19,389
-95% -$30.2K
CALT
5069
DELISTED
Calliditas Therapeutics AB American Depositary Shares
CALT
$2K ﹤0.01%
+76
New +$2.27K
GPACU
5070
DELISTED
Global Partner Acquisition Corp II Unit
GPACU
$2K ﹤0.01%
+200
New +$2.05K
STAF
5071
DELISTED
Staffing 360 Solutions, Inc. Common Stock (DE)
STAF
$2K ﹤0.01%
+4
New +$2.24K
MOTS
5072
DELISTED
Motus GI Holdings, Inc. Common Stock
MOTS
$2K ﹤0.01%
4
-41
-91% -$17.9K
PNT
5073
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
$2K ﹤0.01%
+220
New +$2.98K
CLRG
5074
DELISTED
IndexIQ ETF Trust IQ U.S. Large Cap ETF
CLRG
$2K ﹤0.01%
+77
New +$2.33K
LHC.U
5075
DELISTED
Leo Holdings Corp. II Units, each consisting of one Class A ordinary share and one-quarter of one redeemable warrant
LHC.U
$2K ﹤0.01%
+200
New +$2.06K
201 202
203
204 205

Similar funds

HFCIX
H&F Corporate Investors X San Francisco, California $3.85B AUM
DWM
Destination Wealth Management Walnut Creek, California $3.85B AUM 13% 1-Year Est. Return
TFM
Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return
AC
Anther Capital Hong Kong $3.83B AUM
IP
Interval Partners New York $3.82B AUM 27.38% 1-Year Est. Return
TCIM
TOMS Capital Investment Management New York $3.81B AUM 26.36% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
AFI
American Family Investments Madison, Wisconsin $3.8B AUM 0.71% 1-Year Est. Return

Tower Research Capital (TRC)'s Q1 2021 Portfolio in Review

As of Q1 2021, Tower Research Capital (TRC) held 6,103 positions worth $5.94B, up 82% from $3.27B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Tower Research Capital (TRC) deployed $2.4B of net new capital in Q1 2021, opening 843 new positions and adding to 2,477 existing holdings. Its largest new stake was iShares Russell 1000 Growth ETF: 262,344 shares worth $15.9M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 9.7% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $685M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2021 buy was iShares Russell 1000 Growth ETF: 262,344 shares worth $15.9M.
  • Tower Research Capital (TRC) added most to Apple in Q1 2021, an estimated $206M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $685M.
  • Tower Research Capital (TRC) fully exited ARK Genomic Revolution ETF in Q1 2021, selling an estimated $7.27M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 19% of its $5.94B portfolio in Q1 2021.
  • Tower Research Capital (TRC) opened 843 new positions and closed 546 in Q1 2021.
  • Tower Research Capital (TRC)'s portfolio value rose 82% quarter-over-quarter to $5.94B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2021, filed 17 May 2021.